Expression and diagnostic efficacy of serum DNA polymerase α in Alzheimer's disease
10.3969/j.issn.1673-4130.2024.01.001
- VernacularTitle:血清中DNA聚合酶α在阿尔茨海默病中的表达和诊断价值分析
- Author:
Yue ZHAO
1
;
Jing LIU
;
Xiaomin ZHANG
;
Yuting CUI
;
Peichang WANG
Author Information
1. 首都医科大学宣武医院检验科,北京 100053
- Keywords:
DNA polymerase α;
Alzheimer's disease;
biomarker;
diagnostic value
- From:
International Journal of Laboratory Medicine
2024;45(1):1-5
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression level and diagnostic value of serum DNA polymerase α(DNA pol α)in Alzheimer's disease(AD),and analyze its diagnostic efficacy in AD.Methods A total of 100 patients of dementia of Alzheimer's type(DAT)and 43 patients of mild cognitive impairment(MCI)from Xuanwu Hospital Capital Medical University from March 2019 to April 2023 were included in this study,and 68 healthy individuals of the same age group were collected as the HC group.The expression level of DNA pol α was detected in each group,and the diagnostic value of DNA pol α in AD was analyzed by receiver oper-ating characteristic(ROC)curve.Results The expression level of DNA pol α in DAT group was higher than those in the MCI group(P＜0.05)and the HC group(P＜0.001).The expression level of DNA pol α showed an increasing trend as AD progressed.The expression level of DNA pol α was negatively correlated with Mini Intelligent Mental State Examination Scale(MMSE)score and Montreal Cognitive Assessment Scale(MoCA)score(r=-0.155 3,-0.203 7,P＜0.05).The area under the curve(AUC)of DNA pol α for diagnosing DAT was 0.682,and the sensitivity was 0.900.The AUC for diagnosing MCI was 0.546,and the sensitivity was 0.977.The AUC for differential diagnosis of MCI and DAT was 0.664,the sensitivity was 0.780,and the specificity was 0.535.Conclusion The expression level of DNA pol α is significantly increased in AD patients with DAT,and its expression level is related to the progression of AD,suggesting that DNA pol α has the pos-sibility to be a potential blood biomarker for the diagnosis of AD.
